BidaskClub lowered shares of iKang Healthcare Group (NASDAQ:KANG) from a sell rating to a strong sell rating in a research note issued to investors on Wednesday morning.
Separately, TheStreet lowered shares of iKang Healthcare Group from a c rating to a d+ rating in a research note on Wednesday, August 15th.
Shares of iKang Healthcare Group stock traded down $0.40 during trading on Wednesday, reaching $15.90. The company had a trading volume of 36,019 shares, compared to its average volume of 84,305. The firm has a market cap of $1.19 billion, a PE ratio of 59.21 and a beta of 0.12. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.69 and a current ratio of 0.71. iKang Healthcare Group has a fifty-two week low of $14.21 and a fifty-two week high of $21.01.
Several institutional investors have recently modified their holdings of the company. BlueMountain Capital Management LLC acquired a new stake in shares of iKang Healthcare Group in the 2nd quarter valued at about $130,944,000. Hillhouse Capital Management Ltd. raised its stake in iKang Healthcare Group by 5.0% during the second quarter. Hillhouse Capital Management Ltd. now owns 2,922,834 shares of the medical research company’s stock worth $59,801,000 after acquiring an additional 138,391 shares during the period. Maso Capital Partners Ltd raised its stake in iKang Healthcare Group by 10.5% during the second quarter. Maso Capital Partners Ltd now owns 1,913,280 shares of the medical research company’s stock worth $39,146,000 after acquiring an additional 182,023 shares during the period. Millennium Management LLC raised its stake in iKang Healthcare Group by 338.9% during the second quarter. Millennium Management LLC now owns 1,298,279 shares of the medical research company’s stock worth $26,563,000 after acquiring an additional 1,002,461 shares during the period. Finally, BlackRock Inc. raised its stake in iKang Healthcare Group by 4.3% during the third quarter. BlackRock Inc. now owns 1,000,833 shares of the medical research company’s stock worth $18,116,000 after acquiring an additional 41,424 shares during the period. Institutional investors and hedge funds own 52.13% of the company’s stock.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It operates in two segments, Medical Examinations, and Other Medical Services and Dental Services. The company offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab test, electrocardiogram, ultrasound, and X-ray examination items.
Recommended Story: When is a capital gain realized?
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.